COLINZLABORATORIESLTD logo

Colinz Laboratories Ltd

COLINZLABORATORIESLTD·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap9.10 Cr
PE Ratio3.30
Volume—
Day High - Low—
52W High-Low87.91 - 36.11

Colinz Laboratories Ltd (COLINZLABORATORIESLTD): company summary

Colinz Laboratories Ltd (COLINZLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹9 crore operating in Pharmaceuticals on the NSE and BSE.

Colinz Laboratories Ltd (COLINZLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹9 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been shrinking at -2.6% a year over three years; profit grew 2.8% a year, ahead of revenue — margins are expanding. Return on equity is 5.2%.
Valuation multiples
The stock trades at 3.3 times earnings, a discount to the Healthcare median of 32.0, 1.04 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
5.23%
Weak
P/E
3.30x
Cheap
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

52W₹36.11
₹87.91
DocStoX take

Supported by valuation (6.6) and growth (6.2), but weakest on quality (4.5). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
5.6
/10
Fair
Quality
Modest
ROE 5.2%
Valuation
Fair
P/E 3.3×
Growth
Steady
Revenue +1.4% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹9 Cr
52W High / Low
₹88 / ₹36
Dividend Yield
0.00%
Promoter Holding
50.60%
EPS (TTM)
₹1.98
Book Value
₹69.74

Key highlights

  • Low leverage — D/E 0.04
  • Profitable in all of the last 5 years
  • Undemanding at 3× earnings
  • Revenue barely growing (1% a year)
  • Small ₹9 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Colinz Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.